Improved rodent models of human brain metastases

Clinical and Experimental Metastasis

Volumn 30, Issue 7, 2013, Pages 949-950

  Mathews, Edward Henry ^a,b   Liebenberg, Leon ^a,b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b TEMM International (Pty) Ltd   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BLOOD GLUCOSE MONITORING; BRAIN METASTASIS; CEREBELLUM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; NONHUMAN; RODENT MODEL; SHORT SURVEY; TUMOR MICROENVIRONMENT; TUMOR SEEDING;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84890436634     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9588-3     Document Type: Short Survey

References (20)

1. Daphu I, Sundstrøm T, Horn S, Huszthy PC, Niclou SP, Sakariassen PØ, Immervoll H, Miletic H, Bjerkvig R, Thorsen F (2013) In vivo animal models for studying brain metastasis: value and limitations. Clin Exp Metastasis. doi: 10.1007/s10585-013-9566-9
2. 18F-FDG PET of common enhancing malignant brain tumors. AJR 190(6):W365-W369
3. 18F] fluoro-d-glucose uptake in normal tissues. Mol Imaging Biol 9:83-90
4. Mathews EH, Liebenberg L, Pelzer R (2011) High-glycolytic cancers and their interplay with the body's glucose demand and supply cycle. Med Hypotheses 76:157-165
5. Mathews EH, Liebenberg L (2013) Is knowledge of brain metabolism the key to treating highly glycolytic cancers and metastases? Neuro-Oncology. doi: 10.1093/neuonc/not041
6. Fidler IJ (2011) The role of organ microenvironment on brain metastasis. Semin Cancer Biol 21(2):107-112
7. Lampson LA (2001) New animal models to probe brain tumor biology, therapy, and immunotherapy: advantages and remaining concerns. J Neurooncol 53(3):275-287
8. Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma - are we there yet? Neuro Oncol 15:4-27
9. 18F-FDG in mice. J Nucl Med 52(5):800-807
10. Mizuma H, Shukuri M, Hayashi T, Watanabe Y, Onoe H (2010) Establishment of in vivo brain imaging method in conscious mice. J Nucl Med 51(7):1068-1075
11. Seyfried TN, Shelton LM, Huysentruyt LC (2013) The VM mouse model of glioblastoma multiforme. Neuromethods 77:39-55
12. Vince GH, Bendszuz M, Schweitzer T, Goldbrunner RH, Hildebrandt S, Tilgner J, Klein R, Solymosi L, Tonn JC, Roosen K (2004) Spontaneous regression of experimental gliomas - an immunohistochemical and MRI study of the C6 glioma spheroid implantation model. Exp Neurol 190(2):478-485
13. Mathews EH, Liebenberg L (2011) Revival of 'unsuccessful' chemotherapeutics for highly glycolytic cancers? Med Hypotheses 77(6):1150
14. Mathews EH, Liebenberg L (2013) Cancer control via glucose and glutamine deprivation. J Intern Med. doi: 10.1111/joim.12068
15. Mathews EH, Liebenberg L (2012) Complexity of metabolic cancer control: can we exploit the superior metabolic position of glucose? Cancer Biol Ther 13(8):585
16. Umminger BL (1975) Body size and whole blood sugar concentrations in mammals. Comp Biochem Physiol 52(3):455-458
17. Hanauske AR (2009) In Vitro and In Vivo Predictive Tests. In: Hong WK, Bast RC, Hait WN, Kufe DW (eds) Holland-Frei Cancer Medicine, 8th edn. BC Decker, Hamilton
18. Miura FK, Alves MJF, Rocha MC, da Silva R, Oba-Shinjo SM, Marie SKN (2010) Xenograft transplantation of human malignant astrocytoma cells into immunodeficient rats: an experimental model of glioblastoma. Clinics 65(3):305-309
19. Kamb A (2005) What's wrong with our cancer models? Nat Rev Drug Discov 4(2):161-165
20. HogenEsch H, Nikitin AY (2012) Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models. J Control Release 164(2):183-186